HeartFlow Statistics
Total Valuation
HeartFlow has a market cap or net worth of $1.89 billion. The enterprise value is $1.62 billion.
Important Dates
The next confirmed earnings date is Wednesday, March 18, 2026, after market close.
| Earnings Date | Mar 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HeartFlow has 85.16 million shares outstanding. The number of shares has increased by 247.77% in one year.
| Current Share Class | 85.16M |
| Shares Outstanding | 85.16M |
| Shares Change (YoY) | +247.77% |
| Shares Change (QoQ) | +677.46% |
| Owned by Insiders (%) | 6.44% |
| Owned by Institutions (%) | 63.18% |
| Float | 63.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.65 |
| Forward PS | 9.27 |
| PB Ratio | 7.26 |
| P/TBV Ratio | 7.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.99 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.66, with a Debt / Equity ratio of 0.09.
| Current Ratio | 8.66 |
| Quick Ratio | 8.43 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.07 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -19.10% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $231,589 |
| Profits Per Employee | -$179,358 |
| Employee Count | 699 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, HeartFlow has paid $94,000 in taxes.
| Income Tax | 94,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 29.29 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 36.18 |
| Average Volume (20 Days) | 2,070,100 |
Short Selling Information
The latest short interest is 4.95 million, so 5.81% of the outstanding shares have been sold short.
| Short Interest | 4.95M |
| Short Previous Month | 3.48M |
| Short % of Shares Out | 5.81% |
| Short % of Float | 7.78% |
| Short Ratio (days to cover) | 0.97 |
Income Statement
In the last 12 months, HeartFlow had revenue of $161.88 million and -$125.37 million in losses. Loss per share was -$7.38.
| Revenue | 161.88M |
| Gross Profit | 122.38M |
| Operating Income | -62.37M |
| Pretax Income | -125.28M |
| Net Income | -125.37M |
| EBITDA | -61.91M |
| EBIT | -62.37M |
| Loss Per Share | -$7.38 |
Full Income StatementBalance Sheet
The company has $291.17 million in cash and $21.79 million in debt, with a net cash position of $269.38 million or $3.16 per share.
| Cash & Cash Equivalents | 291.17M |
| Total Debt | 21.79M |
| Net Cash | 269.38M |
| Net Cash Per Share | $3.16 |
| Equity (Book Value) | 254.57M |
| Book Value Per Share | 3.05 |
| Working Capital | 289.94M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$57.47 million and capital expenditures -$3.46 million, giving a free cash flow of -$60.92 million.
| Operating Cash Flow | -57.47M |
| Capital Expenditures | -3.46M |
| Free Cash Flow | -60.92M |
| FCF Per Share | -$0.72 |
Full Cash Flow StatementMargins
Gross margin is 75.60%, with operating and profit margins of -38.53% and -77.45%.
| Gross Margin | 75.60% |
| Operating Margin | -38.53% |
| Pretax Margin | -77.39% |
| Profit Margin | -77.45% |
| EBITDA Margin | -38.25% |
| EBIT Margin | -38.53% |
| FCF Margin | n/a |
Dividends & Yields
HeartFlow does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -247.77% |
| Shareholder Yield | -247.77% |
| Earnings Yield | -6.65% |
| FCF Yield | -3.23% |
Analyst Forecast
The average price target for HeartFlow is $39.20, which is 76.94% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $39.20 |
| Price Target Difference | 76.94% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HeartFlow has an Altman Z-Score of 11.43 and a Piotroski F-Score of 3.
| Altman Z-Score | 11.43 |
| Piotroski F-Score | 3 |
